St. Jude gets $34M to study flu virus
St. Jude Children ’s Research Hospital was founded to fight cancer but is also among the global leaders in influenza research. A person’s lifelong response to the flu may be determined early in life, and a new effort led St. Jude aims to understand that process. And, that research may eventually help create a u niversal flu vaccine. “There is evidence that the very first flu virus encountered — whether as an infection or vaccination — ‘imprints’ on the developing immune system and… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 20, 2019 Category: American Health Authors: Jason Bolton Source Type: news

Africa: Africa Advances On Goal of Cervical Cancer Elimination Across the Continent
[WHO] Brazzaville, 15 May 2019 - The cervical cancer burden falls unequally on Africa, with 19 of the 20 most affected countries on this continent. The disease kills 311 000 women a year worldwide and is the second most common cancer among women in the African region. Yet, cervical cancer is one of the most preventable and curable forms of cancers, through vaccination, early detection and treatment. Bringing cervical cancer to an end is now a priority for the World Health Organization (WHO). (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 16, 2019 Category: African Health Source Type: news

Study shows increased breast cancer risk in transgender women
But absolute risk lower than for the general female population Related items fromOnMedica HPV programme linked to dramatic fall in cervical disease JCVI recommends universal HPV vaccination Data don ’t support HRT for chronic disease prevention Promise to end new HIV transmissions in England by 2030 Breast cancer rate falls with decline in HRT use (Source: OnMedica Latest News)
Source: OnMedica Latest News - May 15, 2019 Category: UK Health Source Type: news

Tanzania: Ministry of Health, Jhpiego Partner Against Cervical Cancer
[Daily News] INTERNATIONAL nonprofit organisation, Jhpiego, in collaboration with the Ministry of Health, Community Development, Gender, Elderly and Children, is intensifying efforts to prevent cervical cancer through Vaccination against Human Papilloma Virus (HPV). (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 14, 2019 Category: African Health Source Type: news

New vaccine offers new hope for pancreatic cancer patients
When cancer develops in the pancreas, the diagnosis often comes after the cancer has already spread (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - May 11, 2019 Category: Consumer Health News Source Type: news

The 4 Types of Doctors Visits You Should Make For a Long, Healthy Life
Prevention is often called the best medicine — but research has shown that millions of Americans are not getting the preventive care they should to live long, healthy lives. Obstacles like inadequate access to care and financial barriers can keep people away from the doctor, but anxiety and feeling like care is unnecessary are also common deterrents. “There are a lot of things that every person could do to stay healthy, and this could help people to feel better, improve their quality of life and help them to live longer,” says Dr. Alex Krist, a professor of family medicine at Virginia Commonwealth Univer...
Source: TIME: Health - May 10, 2019 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Longevity public health Source Type: news

Vaccine design can dramatically improve cancer immunotherapies
(Northwestern University) After comparing a series of compositionally identical yet structurally different vaccines by testing them on multiple animal models, Northwestern University researchers found the structure of SNAs in one vaccine dramatically outperformed the others, which ranged from ineffective to nearly curative. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 6, 2019 Category: Cancer & Oncology Source Type: news

Medical News Today: Colorectal cancer vaccine has promising results in early trials
Researchers have revealed positive results of a small, early clinical trial that tested the effects of a new vaccine on 10 people with colorectal cancer. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 5, 2019 Category: Consumer Health News Tags: Colorectal Cancer Source Type: news

Coolest Office Spaces: Morphogenesis creates interactive spaces for big minds
Morphogenesis is a clinical stage immunotherapy company headquartered in Tampa. The company ’s principal focus is a platform of cancer vaccines that utilize both cell and gene therapies to stimulate the immune system to recognize and combat tumor cells. Since the company is involved in research, development and manufacturing, a unique, creative environment is critical. Eighty percent of the team has advanced degrees, with seven Ph.D.s, three advanced medical degrees, two CPAs and seven master’s… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 3, 2019 Category: American Health Authors: Pam Huff Source Type: news

Opting In: The Value of Vaccines
A young boy in Pakistan receives an oral polio vaccine (OPV). Over the last 30 years huge progress has been made against polio and it is now only endemic in 2 countries, Afghanistan and Pakistan, with only 33 cases confirmed cases last year. Credit: Ashfaq Yusufzai/IPSBy Tharanga YakupitiyageUNITED NATIONS, May 1 2019 (IPS) Since the introduction of vaccines, diseases such as measles and polio were quickly becoming a thing of the past. However, the world’s progress on immunisation is now being threatened. According to the World Health Organisation (WHO), 85 percent of the world’s children received basic va...
Source: IPS Inter Press Service - Health - May 1, 2019 Category: International Medicine & Public Health Authors: Tharanga Yakupitiyage Tags: Featured Global Headlines Health IPS UN: Inside the Glasshouse North America Population Regional Categories TerraViva United Nations diptheria-tetanus-pertussis (DTP) human papillomavirus (HPV) Measles Vaccines World Health Organ Source Type: news

UCLA microbiologist Patricia J. Johnson elected to National Academy of Sciences
Patricia J. Johnson, UCLA professor of microbiology, immunology and molecular genetics, was elected to the National Academy of Sciences in recognition of her “distinguished and continuing achievements in original research.”Membership in the academy is one of the highest honors that a U.S. scientist can receive. Its members have included Albert Einstein, Thomas Edison, Orville Wright and Alexander Graham Bell. The academy today announced the election of 100 new members and 25 foreign associates.“I am very honored to be include among the ranks of such distinguished scientists,” said Johnson, who has a...
Source: UCLA Newsroom: Health Sciences - May 1, 2019 Category: Universities & Medical Training Source Type: news

Urine test could end fear of smears
Trials suggest simple home test could replace discomfort or embarrassment of smears Related items fromOnMedica Four in five girls have had HPV jab One or two doses of HPV jab may be enough Nurse guidance published on cervical cancer and HPV Parents unsure of HPV vaccine for daughters Preventing cervical cancer: how a screening switch and HPV vaccination should cut cancer rates (Source: OnMedica Latest News)
Source: OnMedica Latest News - April 30, 2019 Category: UK Health Source Type: news

Should You Get a Measles Booster Shot? Here ’s What Experts Say
Unvaccinated individuals have been the focus of attention during this year’s measles outbreaks. A record 704 cases of the illness have been confirmed in 22 states so far in 2019, and the CDC says the majority of those diagnoses have been in unvaccinated people. Health officials have repeatedly warned nearly everyone to get the shot if they haven’t already — sometimes threatening fines for those who refuse. “Over 90% of the measles cases that have occurred in the U.S. have occurred in unvaccinated persons,” says Dr. William Schaffner, a professor of preventive medicine and infectious diseases a...
Source: TIME: Health - April 29, 2019 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized public health Source Type: news

Novel vaccine for colorectal cancer shows positive phase I results
(Thomas Jefferson University) The vaccine proves safe in a small sample of human subjects, opening the way for the next phase of testing. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 25, 2019 Category: Cancer & Oncology Source Type: news

Optimism High for Mesothelioma Immunotherapy Clinical Trial in Europe
A novel clinical trial aiming to train the immune system to recognize and attack pleural mesothelioma tumor cells has opened with considerable optimism across five European countries. The randomized phase II/III study is designed to measure the efficacy and anti-tumor activity of MesoPher, a vaccine combining a patient’s own dendritic immune cells with a specially engineered cell line. The multicenter study, which is hoping for 235 participants, has opened in Antwerp, Belgium; Lille, France; Ancona, Italy; Amsterdam and Rotterdam, Netherlands and Leicester, England. “There is hope, a lot of hope, with this stud...
Source: Asbestos and Mesothelioma News - April 23, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

HPV Vaccine Driving Down Cervical Pre-Cancer Rates
(Source: Cancercompass News: Gynecological Cancer)
Source: Cancercompass News: Gynecological Cancer - April 19, 2019 Category: Cancer & Oncology Source Type: news

HPV Vaccine Driving Down Cervical Pre - Cancer Rates
(Source: Fertility News - Doctors Lounge)
Source: Fertility News - Doctors Lounge - April 18, 2019 Category: Reproduction Medicine Tags: Infections, Oncology, Reproductive Medicine, News, Source Type: news

A Gene Therapy Breakthrough Could Offer a Treatment for the Rare and Deadly ‘Bubble Boy’ Disease
Researchers used an experimental gene therapy to develop a possible treatment for a rare and deadly immune disorder known as “bubble boy” disease, the National Institutes of Health (NIH) announced Wednesday. Because of a gene mutation, babies who are born with X-linked severe combined immunodeficiency (X-SCID) do not develop immune cells properly, leaving them highly susceptible to infections. The condition, which strikes up to one in 50,000 newborns, primarily affects boys and requires extreme measures to prevent infection. In one famous case, a boy with SCID, David Vetter, lived in a sterile plastic “bu...
Source: TIME: Health - April 18, 2019 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Research Source Type: news

Circuit Clinical partners with Roswell Park for lung cancer clinical trials
Roswell Park patients will use Circuit Clinical's new TrialScout app to connect to clinical trial opportunities for the CIMIvax lung cancer vaccine. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - April 18, 2019 Category: American Health Authors: Tracey Drury Source Type: news

HPV Vaccine Driving Down Cervical Pre-Cancer Rates
THURSDAY, April 18, 2019 -- The human papillomavirus (HPV) vaccine is largely responsible for a decline in precancerous cervical lesions among young women in the United States, a new government report shows. The number of these precancerous lesions... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 18, 2019 Category: General Medicine Source Type: news

Cervical cancer subtype rising in some sub-populations
(American Cancer Society) A new study reports that a type of cervical cancer that is less amenable to Pap testing is increasing in several subpopulations of women, pointing to the growing importance of human papillomavirus (HPV) testing and vaccination (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 17, 2019 Category: International Medicine & Public Health Source Type: news

Exclusive: Philadelphia startup breaks new ground against cancer that killed John McCain
The company, founded by Jefferson researchers, posted positive clinical trial data from an early study testing its immunotherapy vaccine in patients with glioblastoma. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - April 15, 2019 Category: American Health Authors: John George Source Type: news

The HPV vaccine is important for preteens and teenagers. What about older women?
A doctor explores the pros and cons of a 45-year-old getting the shots against a disease that can cause cervical, oral and anal cancers. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - April 13, 2019 Category: Consumer Health News Authors: Daphne Miller Source Type: news

Childhood HPV vaccine lowers precursor to cervical cancer 'greater than expected'
Young women who received HPV vaccines have lower rates of precursor to cervical cancer, study finds. (Source: CBC | Health)
Source: CBC | Health - April 12, 2019 Category: Consumer Health News Tags: News/Health Source Type: news

Why the HPV Vaccine Is More Important Than Ever
(Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - April 12, 2019 Category: Cancer & Oncology Source Type: news

We Finally Learned What a Year in Space Did to Astronaut Scott Kelly ’s Body
Traveling in space looks like all kinds of fun, and in a lot of respects, it is—provided you can overlook a few downsides. There’s the loss of muscle mass, for one thing. Then there’s the decalcification of bones and the stress on the heart and the damage to the eyes and the changes in the immune system and the disruption of the genome and an actual shortening of your overall life expectancy. It was, in part, to study all of those biological problems that astronaut Scott Kelly spent 340 days in space from 2015 to 2016 (chronicled in TIME’s Emmy-nominated series A Year in Space). Now, just over three...
Source: TIME: Health - April 11, 2019 Category: Consumer Health News Authors: Jeffrey Kluger Tags: Uncategorized onetime space Year in Space Source Type: news

We Finally Learned What a Year in Space Did to Astronaut Scott Kelly ’s Body
Traveling in space looks like all kinds of fun, and in a lot of respects, it is—provided you can overlook a few downsides. There’s the loss of muscle mass, for one thing. Then there’s the decalcification of bones and the stress on the heart and the damage to the eyes and the changes in the immune system and the disruption of the genome and an actual shortening of your overall life expectancy. It was, in part, to study all of those biological problems that astronaut Scott Kelly spent 340 days in space from 2015 to 2016 (chronicled in TIME’s Emmy-nominated series A Year in Space). Now, just over three...
Source: TIME: Science - April 11, 2019 Category: Science Authors: Jeffrey Kluger Tags: Uncategorized onetime space Year in Space Source Type: news

Liver cancer rising among poorer people
Men with low rates of educational attainment are at greatest risk Related items fromOnMedica HPV programme linked to dramatic fall in cervical disease Cancer mortality cut by a third in young people Well over half of people have never had an STI test JCVI recommends universal HPV vaccination FOB associated with rise in all-cause mortality (Source: OnMedica Latest News)
Source: OnMedica Latest News - April 11, 2019 Category: UK Health Source Type: news

Childhood HPV vaccination 'profoundly' cuts cervical disease in young women
(Reuters Health) - - Young women who received human papillomavirus (HPV) vaccines as adolescents had significantly lower rates of a condition that's a precursor to cervical cancer, in a nationwide study in Scotland. (Source: Reuters: Health)
Source: Reuters: Health - April 10, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

New 'Cancer Vaccine' Attacks Tumors From Within
Title: New 'Cancer Vaccine' Attacks Tumors From WithinCategory: Health NewsCreated: 4/9/2019 12:00:00 AMLast Editorial Review: 4/10/2019 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - April 10, 2019 Category: Cancer & Oncology Source Type: news

New 'Cancer Vaccine' Attacks Tumors From Within
(Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - April 10, 2019 Category: Cancer & Oncology Source Type: news

New 'Cancer Vaccine' Attacks Tumors From Within
Eight out of 11 lymphoma patients in a small, early clinical trial had partial or complete destruction of the tumor that received the initial injection, according to the researchers’ report. (Source: WebMD Health)
Source: WebMD Health - April 9, 2019 Category: Consumer Health News Source Type: news

New ‘ Cancer Vaccine ’ Attacks Tumors From Within
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - April 9, 2019 Category: Cancer & Oncology Tags: Infections, Nursing, Oncology, Pharmacy, Research, News, Source Type: news

NIH researchers make progress toward Epstein-Barr virus vaccine
EBV is herpesvirus that causes infectious mononucleosis and is associated with certain cancers. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - April 9, 2019 Category: American Health Source Type: news

New'Cancer Vaccine' Attacks Tumors From Within
TUESDAY, April 9, 2019 -- A new method of brewing a cancer vaccine inside a patient's tumor could harness the power of the immune system to destroy the disease, researchers report. Immune stimulants are injected directly into a tumor, which teaches... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 9, 2019 Category: General Medicine Source Type: news

Experimental cancer vaccine that teaches the body destroy tumours sends patients into remission
Researchers at New York's Mount Sinai Hospital created the treatment that is injected into the tumour to stimulate the immune system (stock) (Source: the Mail online | Health)
Source: the Mail online | Health - April 9, 2019 Category: Consumer Health News Source Type: news

NIH researchers make progress toward Epstein-Barr virus vaccine
(NIH/National Institute of Allergy and Infectious Diseases) A research team led by scientists from NIH's National Institute of Allergy and Infectious Diseases (NIAID) has determined how several antibodies induced by Epstein-Barr virus (EBV), a herpesvirus that causes infectious mononucleosis and is associated with certain cancers, block infection of cells grown in the laboratory. They then used this information to develop novel vaccine candidates that, in animals, elicited potent anti-EBV antibody responses that blocked infection of cell types involved in EBV-associated cancers. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 9, 2019 Category: Infectious Diseases Source Type: news

Immune-therapy could combat cancer
Injections into tumours could turn them into 'cancer vaccine factories' Related items fromOnMedica Patient's sex might affect immunotherapy outcomes Cancer survival rates not improved much in a decade Cancer survivors more prone to stress than others Free prescriptions for cancer patients Cancer cases in older people set to surge (Source: OnMedica Latest News)
Source: OnMedica Latest News - April 9, 2019 Category: UK Health Source Type: news

Another Study Says HPV Shot Cuts Cervical Cancer
The younger the age at vaccination, the more effective the vaccine, the findings showed. (Source: WebMD Health)
Source: WebMD Health - April 8, 2019 Category: Consumer Health News Source Type: news

Cancer vaccine: Treatment shows promising results in shrinking tumours
CANCER: More than one in three people will develop cancer during their lifetime, according to figures. There ’s currently no cure, but as scientists advance in their research for a successful treatment, a new study has shown a vaccine to be effective at shrinking cancerous tumours. (Source: Daily Express - Health)
Source: Daily Express - Health - April 8, 2019 Category: Consumer Health News Source Type: news

The WHO technical report on the pricing of cancer medicine: missing a central role for value assessment
This report reviews the 2018 report on cancer pricing, Pricing of cancer medicines and its impacts, published by the World Health Organization (WHO). The authors argue that the report fails to promote mechanisms (value assessment and related pricing arrangements) that are key to efficient pricing and use of cancer medicines. This is a missed opportunity. WHO should also support differential pricing of on-patent drugs and vaccines, which is crucial to increasing access. It should oppose the Report ’s advocacy of transparency of on-patent pricing, which will reduce access to medicines.ReportPress release (Sou...
Source: The Kings Fund - Health Management Specialist Collection - April 8, 2019 Category: Health Management Authors: The King ' s Fund Information & Knowledge Service Tags: NHS finances and productivity Source Type: news

Gene Therapy Trial for Mesothelioma Opens Internationally
A long-awaited phase III clinical trial of a novel gene therapy could change malignant pleural mesothelioma treatment in the future. The trial, which will include almost 50 locations around the world, opens this month for mesothelioma patients whose standard treatment has stopped working. The gene therapy drug, called TR002, is also a form of immunotherapy. It will be used in combination with gemcitabine chemotherapy in a second-line setting. “We can’t predict what the outcome will be, but we’re very excited about the potential of this treatment, and the fact there may be another drug in the armamentarium...
Source: Asbestos and Mesothelioma News - April 8, 2019 Category: Environmental Health Authors: Daniel King Source Type: news

More Evidence HPV Vaccine Cuts Cervical Cancer Rate
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - April 8, 2019 Category: Cancer & Oncology Tags: Gynecology, Infections, Oncology, Pediatrics, News, Source Type: news

More Evidence HPV Vaccine Cuts Cervical Cancer Rate
MONDAY, April 8, 2019 -- Scotland is already seeing a payoff for vaccinating adolescent girls for human papillomavirus (HPV). Since the vaccine became routine about a decade ago, cervical cancer cases in young Scottish women have plummeted, a new... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 8, 2019 Category: General Medicine Source Type: news

Mount Sinai researchers develop treatment that turns tumors into cancer vaccine factories
(The Mount Sinai Hospital / Mount Sinai School of Medicine) Researchers at Mount Sinai have developed a novel approach to cancer immunotherapy, injecting immune stimulants directly into a tumor to teach the immune system to destroy it and other tumor cells throughout the body. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 8, 2019 Category: Cancer & Oncology Source Type: news

More Evidence HPV Vaccine Cuts Cervical Cancer Rate
(Source: Cancercompass News: Gynecological Cancer)
Source: Cancercompass News: Gynecological Cancer - April 8, 2019 Category: Cancer & Oncology Source Type: news

Potential Role of the HPV Vaccine in Preventing Non-Melanoma Skin Cancers
The association between the presence of several viruses and non-melanoma skin cancer was investigated in a recent study. (Source: CancerNetwork)
Source: CancerNetwork - April 5, 2019 Category: Cancer & Oncology Authors: Naveed Saleh, MD, MS Source Type: news

Experimental vaccine clears up cervical pre-cancer lesions and HPV infection in one-third of women
A new study from Michigan Medicine has found that a new vaccine not only cleared up severe precancerous lesions in women caused by HPV, but also cleared the infection itself. (Source: the Mail online | Health)
Source: the Mail online | Health - April 4, 2019 Category: Consumer Health News Source Type: news

HPV vaccine: What is HPV? How does it cause cervical cancer?
HPV IMMUNISATION has led to a dramatic decline in the disease in Scotland, according to new data released by the British Medical Journal. What is HPV and how does it cause cervical cancer? (Source: Daily Express - Health)
Source: Daily Express - Health - April 4, 2019 Category: Consumer Health News Source Type: news

Vaccinating 12-to-13 year old girls against HPV reduces their risk of cervical cancer
All schoolgirls in the UK have been offered the human papillomavirus vaccine at the age of 12 or 13 since 2008. The new study was conducted on 138,000 women. (Source: the Mail online | Health)
Source: the Mail online | Health - April 4, 2019 Category: Consumer Health News Source Type: news